Tehran, February 2025 – Dr. Ali Faraji, CEO of the knowledge-based company Atra Zist Aray (ticker: “DATRA”), emphasized that the company’s entry into the capital market provides a valuable opportunity for expanding production lines, fostering collaborations with distribution companies, strengthening R&D infrastructure, and broadening export activities.
According to Atra Zist Aray’s Public Relations and citing the Tehran Stock Exchange’s Communications Department, Dr. Faraji stated: “The significance of Atra Zist Aray’s initial public offering extends beyond capital raising; this move can substantially contribute to increasing transparency, enhancing competitiveness, and advancing the domestic medical technology production industry, thereby creating employment opportunities and promoting sustainable market growth.”
Highlighting the importance of entering the capital market, he added: “Atra Zist Aray, as one of the leading Iranian brands in therapeutic and aesthetic products, is taking a significant step towards development and innovation through its capital market debut.”
Dr. Faraji further introduced the company’s key products: “This company, which manufactures products such as Dyston (Botulinum Toxin Type A), Luxiva mesogel, and Florivissage specialized serums, has successfully captured a significant share of both domestic and export markets by leveraging indigenous technology.”
The CEO of Atra Zist Aray underscored the company’s commitment to quality, innovation, efficacy, and safety, stating: “We strive to play a more prominent role in enhancing societal health and rejuvenation, and the initial public offering serves as a crucial step in achieving these long-term objectives.”
Conclusion
Atra Zist Aray’s initial public offering on the stock exchange is not merely a financial milestone but a key strategy for accelerating growth, fostering innovation, and expanding its footprint in both domestic and international markets. This initiative underscores the company’s maturity and readiness to embark on a new phase of development within the medical and aesthetic products industry.
بدون دیدگاه